DE:INFLARX
InflaRx
- Stock
locale
Germanymarket
STOCKSindustry
Biotechnologywebsite
www.inflarx.delinkedin
inflarxipo date
Nov 07, 2017
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory...Show More